Hydroxychloroquine Adamed

Hydroxychloroquine, the active ingredient in Hydroxychloroquine Adamed, is an antimalarial presented as a tablet for oral use. It treats malaria, rheumatoid arthritis and systemic lupus erythematosus and is indicated for acute malaria episodes as well as long‑term management of these autoimmune disorders.

GNH USA supplies Hydroxychloroquine Adamed as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to WHO‑GMP standards and provides reliable logistics for global distribution to healthcare providers. Ensuring timely delivery and product integrity across regions.

Hydroxychloroquine is an antimalarial agent that also modulates immune activity in rheumatic diseases.

Malaria: effective treatment of acute malaria infections, reducing parasitic replication. Rheumatoid arthritis: helps lower disease activity and joint inflammation in patients with RA. Systemic lupus erythematosus: assists in controlling disease flares and cutaneous manifestations.

Hydroxychloroquine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Abdominal pain - Headache - Skin rash

Serious or Rare Side Effects: - Retinopathy leading to vision loss - Cardiomyopathy or arrhythmias - Severe hypoglycemia - Blood dyscrasias such as agranulocytosis - Neuropsychiatric disturbances

Before initiating therapy, consider the following precautions to ensure safe use of hydroxychloroquine. - Pregnancy: safety not established; use only if benefit outweighs risk. - Renal impairment: dose may need adjustment; monitor renal function. - Ophthalmologic monitoring: baseline eye exam and periodic follow‑up recommended. - Cardiac risk: assess QT interval and avoid in patients with known prolongation. - Concomitant drugs: review for interactions that may increase toxicity. - Store at ambient temperature: keep in original container, protect from moisture.

Hydroxychloroquine can interact with several medicines; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption. - Quinidine and other class I antiarrhythmics: increase cardiotoxic risk. - Digoxin: may raise serum levels. - Cyclosporine: enhanced toxicity risk. - Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): increase hydroxychloroquine concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect. - Insulin or oral hypoglycemics: risk of hypoglycemia. - Other QT‑prolonging agents (e.g., azithromycin, fluoroquinolones): monitor cardiac rhythm. - Rifampin: may decrease hydroxychloroquine levels. - Zidovudine: potential additive hematologic toxicity.